Search research articles
Contact Us
Filters
Showing results (101-110 of 411) with videos related to
Page
of 42
Sort By:
Cancer Treatment Reviews
|
March 1, 1990
Clinical applications of myeloid colony stimulating factors
W P Steward, N Thatcher, S B Kaye
British Journal of Cancer
|
January 28, 2012
Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies?
N Tunariu, S B Kaye, N M Desouza
Anti-Cancer Drugs
|
January 1, 1997
Protein kinase C: a worthwhile target for anticancer drugs?
F Caponigro, R C French, S B Kaye
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 1999
Basic research: how much do we know, and what are we likely to learn about ovarian cancer in the near future?
T C Hamilton, J S Berek, S B Kaye
Indian Journal of Ophthalmology
|
March 23, 1999
Central corneal endothelial guttae and age-related macular degeneration: is there an association?
G P Rao, S B Kaye, A Agius-Fernandez
Lancet (London, England)
|
May 29, 1976
Letter: Bromocriptine and hypertension
S B Kaye, K M Shaw, E J Ross
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1995
Docetaxel in advanced ovarian cancer: preliminary results from three phase II trials. EORTC Early Clinical Trials Group and Clinical Screening Group, and the MD Anderson Cancer Center
S B Kaye, M Piccart, M Aapro, et al.
Lancet (London, England)
|
October 31, 1992
Who should receive a 5-HT3 antagonist?
S B Kaye, D Khayat, M Aapro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1994
Primary mediastinal germ cell tumour and acute monocytic leukaemia occurring concurrently in a 15-year-old boy
P A Vasey, D J Dunlop, S B Kaye
European Journal of Cancer
|
March 1, 1981
The effect of liposome (phospholipid vesicle) entrapment of actinomycin D and methotrexate on the in vivo treatment of sensitive and resistant solid murine tumours
S B Kaye, J A Boden, B E Ryman
Page
of 42
Search research articles
Search
Showing results (101-110 of 411) with videos related to
Sort By:
Page
of 42
Cancer Treatment Reviews
|
March 1, 1990
Clinical applications of myeloid colony stimulating factors
W P Steward, N Thatcher, S B Kaye
British Journal of Cancer
|
January 28, 2012
Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies?
N Tunariu, S B Kaye, N M Desouza
Anti-Cancer Drugs
|
January 1, 1997
Protein kinase C: a worthwhile target for anticancer drugs?
F Caponigro, R C French, S B Kaye
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 1999
Basic research: how much do we know, and what are we likely to learn about ovarian cancer in the near future?
T C Hamilton, J S Berek, S B Kaye
Indian Journal of Ophthalmology
|
March 23, 1999
Central corneal endothelial guttae and age-related macular degeneration: is there an association?
G P Rao, S B Kaye, A Agius-Fernandez
Lancet (London, England)
|
May 29, 1976
Letter: Bromocriptine and hypertension
S B Kaye, K M Shaw, E J Ross
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1995
Docetaxel in advanced ovarian cancer: preliminary results from three phase II trials. EORTC Early Clinical Trials Group and Clinical Screening Group, and the MD Anderson Cancer Center
S B Kaye, M Piccart, M Aapro, et al.
Lancet (London, England)
|
October 31, 1992
Who should receive a 5-HT3 antagonist?
S B Kaye, D Khayat, M Aapro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1994
Primary mediastinal germ cell tumour and acute monocytic leukaemia occurring concurrently in a 15-year-old boy
P A Vasey, D J Dunlop, S B Kaye
European Journal of Cancer
|
March 1, 1981
The effect of liposome (phospholipid vesicle) entrapment of actinomycin D and methotrexate on the in vivo treatment of sensitive and resistant solid murine tumours
S B Kaye, J A Boden, B E Ryman
Page
of 42